Evidence-Grounded Agentic Formulation Development in an Autonomous Laboratory
Focuses on Evidence-Grounded Agentic Formulation Development in an Autonomous Laboratory.
At a glance
- Source
- arXiv
- Published
- Sep 17, 2026
- Read time
- 1 min read
- Primary lane
- Machine Learning
Quick read
3 bullets- Focuses on Evidence-Grounded Agentic Formulation Development in an Autonomous Laboratory.
- Self-emulsifying drug delivery systems (SEDDS) can improve the oral bioavailability of poorly soluble drugs, but identifying high-performing formulations remains experimentally intensive.
- We present Andromeda 2, an agentic system that reasons over structured in-house experimental evidence and invokes computational and experimental tools to design and execute successive formulation batches.
Why it matters
Clinical and bio workflows punish fragile models quickly. What matters here is whether the method improves trust, robustness, or operational cost enough to make it usable in expensive real settings.
Builder takeaway
arXiv published this update in the Machine Learning lane. Use the original source for details, then compare it with related briefings before changing a roadmap, workflow, or production system.
Clinical and bio workflows punish fragile models quickly. What matters here is whether the method improves trust, robustness, or operational cost enough to make it usable in expensive real settings.
Stay ahead with daily AI briefings
Follow the feed, share the briefing, or jump back into the archive.